Ailin Qu

1.1k total citations
21 papers, 752 citations indexed

About

Ailin Qu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ailin Qu has authored 21 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Ailin Qu's work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (6 papers). Ailin Qu is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (6 papers). Ailin Qu collaborates with scholars based in China and United States. Ailin Qu's co-authors include Chuanxin Wang, Lutao Du, Guixi Zheng, Yongmei Yang, Xin Zhang, Yimin Liu, Lili Wang, Xiumei Jiang, Zhaogang Dong and Juan Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Cancer.

In The Last Decade

Ailin Qu

19 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ailin Qu China 16 563 541 106 76 66 21 752
Yingjun Xie China 11 366 0.7× 423 0.8× 44 0.4× 76 1.0× 121 1.8× 20 623
Susanne Raulefs Germany 9 236 0.4× 314 0.6× 57 0.5× 50 0.7× 142 2.2× 21 451
Shouguo Sun China 10 403 0.7× 527 1.0× 78 0.7× 98 1.3× 117 1.8× 12 662
Emre Özgür Türkiye 11 801 1.4× 801 1.5× 41 0.4× 69 0.9× 52 0.8× 31 925
Linda Fabris United States 14 477 0.8× 581 1.1× 30 0.3× 112 1.5× 196 3.0× 19 803
Xun Zhu China 10 421 0.7× 492 0.9× 27 0.3× 45 0.6× 79 1.2× 16 610
Shaohua Qu China 8 522 0.9× 523 1.0× 44 0.4× 47 0.6× 201 3.0× 12 777
Weimei Huang China 13 597 1.1× 766 1.4× 34 0.3× 181 2.4× 153 2.3× 29 937
P. Anoop Chandran Germany 9 317 0.6× 351 0.6× 43 0.4× 74 1.0× 82 1.2× 12 619

Countries citing papers authored by Ailin Qu

Since Specialization
Citations

This map shows the geographic impact of Ailin Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailin Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailin Qu more than expected).

Fields of papers citing papers by Ailin Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailin Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailin Qu. The network helps show where Ailin Qu may publish in the future.

Co-authorship network of co-authors of Ailin Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Ailin Qu. A scholar is included among the top collaborators of Ailin Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailin Qu. Ailin Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xiumei, et al.. (2024). RNA-seq profiling identified a three-lncRNA panel in serum as potential biomarker for muscle-invasive bladder cancer. Frontiers in Oncology. 14. 1451009–1451009. 1 indexed citations
2.
Qu, Ailin, et al.. (2024). SF3B4 downregulation restrains lung adenocarcinoma tumorigenesis via 5′ alternative splicing of KAT2A. Scientific Reports. 14(1). 30–30. 5 indexed citations
3.
4.
Qu, Ailin, Qian Wang, Qing Chang, et al.. (2023). Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer. Scientific Reports. 13(1). 1350–1350. 4 indexed citations
5.
Zhao, Rui, Xin Zhang, Yanli Zhang, et al.. (2020). HOTTIP Predicts Poor Survival in Gastric Cancer Patients and Contributes to Cisplatin Resistance by Sponging miR-216a-5p. Frontiers in Cell and Developmental Biology. 8. 348–348. 23 indexed citations
6.
Zheng, Guixi, Yuzhi Zhang, Hongchun Wang, et al.. (2020). Genome‐wide DNA methylation analysis by MethylRad and the transcriptome profiles reveal the potential cancer‐related lncRNAs in colon cancer. Cancer Medicine. 9(20). 7601–7612. 5 indexed citations
7.
Qu, Ailin, Wenfei Wang, Yongmei Yang, et al.. (2019). <p>A serum piRNA signature as promising non-invasive diagnostic and prognostic biomarkers for colorectal cancer</p>. Cancer Management and Research. Volume 11. 3703–3720. 70 indexed citations
8.
Qu, Ailin, Yongmei Yang, Xin Zhang, et al.. (2018). Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans. EBioMedicine. 37. 125–133. 37 indexed citations
9.
Yang, Yongmei, Ailin Qu, Xin Zhang, et al.. (2018). Genome‐wide identification of a novel miRNA‐based signature to predict recurrence in patients with gastric cancer. Molecular Oncology. 12(12). 2072–2084. 26 indexed citations
10.
Zheng, Guixi, et al.. (2016). miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer. World Journal of Gastroenterology. 22(24). 5589–5589. 18 indexed citations
11.
Wang, Wenhui, et al.. (2016). Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer. European Journal of Cancer Care. 26(4). e12448–e12448. 49 indexed citations
12.
Yang, Yongmei, Ailin Qu, Rui Wang, et al.. (2015). Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer. PLoS ONE. 10(8). e0135168–e0135168. 37 indexed citations
13.
Yang, Yongmei, Lutao Du, Zhaogang Dong, et al.. (2014). Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Medical Oncology. 31(11). 256–256. 30 indexed citations
14.
Zhang, Xin, Yongmei Yang, Zewu Li, et al.. (2014). Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer. Medical Oncology. 31(10). 197–197. 37 indexed citations
15.
Gao, Yang, Yimin Liu, Lutao Du, et al.. (2014). Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior. Medical Oncology. 32(1). 362–362. 62 indexed citations
16.
Jiang, Xiumei, Lutao Du, Lili Wang, et al.. (2014). Serum microRNA expression signatures identified from genome‐wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. International Journal of Cancer. 136(4). 854–862. 120 indexed citations
17.
Zheng, Guixi, Haiyan Wang, Xin Zhang, et al.. (2013). Identification and Validation of Reference Genes for qPCR Detection of Serum microRNAs in Colorectal Adenocarcinoma Patients. PLoS ONE. 8(12). e83025–e83025. 93 indexed citations
18.
Wang, Haiyan, Xin Zhang, Lili Wang, et al.. (2013). Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer. Journal of Surgical Oncology. 109(6). 574–579. 30 indexed citations
19.
Dong, Zhaogang, Lutao Du, Xiaofei Xu, et al.. (2013). Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis. International Journal of Molecular Medicine. 31(4). 989–997. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingjun Xie Breakdown of academic impact, for papers by Susanne Raulefs Breakdown of academic impact, for papers by Shouguo Sun Breakdown of academic impact, for papers by Emre Özgür Breakdown of academic impact, for papers by Linda Fabris Breakdown of academic impact, for papers by Xun Zhu Breakdown of academic impact, for papers by Shaohua Qu Breakdown of academic impact, for papers by Weimei Huang Breakdown of academic impact, for papers by P. Anoop Chandran
Rankless by CCL
2026